AI in Healthcare, Nearly 2 Billion and Growing

Kalorama Information’s report, The Market for Artificial Intelligence (AI) in Healthcare, quantifies the opportunity and future market opportunity for AI in healthcare, already an almost two-billion-dollar market, with applications in workflow and population health, drug discovery and emerging applications in diagnostics and other areas. The Market for Artificial Intelligence (AI) in Healthcare In the United […]

READ MORE..


New Report Focuses on NASH Market Opportunity

It’s no surprise that many pharmaceutical companies are developing treatments for a disease affecting millions with no current therapy.  That disease is Non-alcoholic fatty liver disease (NAFLD).  NASH is a  lifestyle disease (obesity and lack of exercise) and is distinct from other fatty liver diseases caused by alcohol abuse or medication side effects.  The symptoms […]

READ MORE..


NT-proBNP comes of age for preoperative prediction of CV risks

From www.labpulse.com December 24, 2019 — Testing blood for N-terminal pro b-type natriuretic peptide (NT-proBNP) appears to have value as a preoperative test to predict risk of cardiovascular (CV) events, according to a study published December 24 online in Annals of Internal Medicine. The results may prompt a rethink of cardiology guidelines, which currently do not advise […]

READ MORE..


Karius Test Demonstrates Ability To Detect Bloodstream Infections In Pediatric Patients With Cancer Before Symptoms Develop

Karius, a life sciences company, announced today that JAMA Oncology published a clinical study showing that the Karius Test detected bloodstream infections before the onset of clinical symptoms in high-risk pediatric patients with relapsed or refractory leukemia. The study was performed by researchers at St. Jude Children’s Research Hospital and provides the first evidence that the Karius Test […]

READ MORE..


The Promising Growth of the Live Cell Imaging Market in 2019

Live cell imaging technologies have become an essential component of life science research on a global scale. Over the years, live cell imaging technologies have become easier to use for customers to conduct their research, such as drug discovery. Also, the market’s consumables and aftermarket products have experienced an increase in demand due to their […]

READ MORE..


Top 10 Life Science and Healthcare Market Predictions for 2020

Highly effective cancer therapies. Handheld hematology analyzers. A new and untapped world market. Social media selling life science tools. Science and Medicine Group publications, including Kalorama Information, Strategic Directions International (SDi), Bioinformatics, and IMV have made various projections for the new year in imaging, diagnostics, biotechnology, and life science instrument and supplies that can help […]

READ MORE..


Kalorama Presents at BIOMedevice San Jose

The point of care diagnostic testing market is over $22 billion, about 2/3rds of that is self-care and physician office based testing. Point of care testing offers significant benefits in time-to-results, time-to-treatment, diagnostic relevance to providers and even patient confidence.  They tend to cost more than lab-based tests, but in an overall context of care […]

READ MORE..


Decentralized Hematology Tests Driving Market

Hematology is the study of peripheral blood and bone marrow cells in order to diagnose various diseases of the blood including leukemias, anemia and autoimmune diseases. Kalorama Information has covered hematology for decades in its report The Worldwide Market for In Vitro Diagnostic Tests https://kaloramainformation.com/product/the-world-market-for-in-vitro-diagnostic-tests-12th-edition/ The basis of hematology testing is the complete blood count […]

READ MORE..


Same – Day NGS Cancer Testing, New Liquid Bx, DNA/RNA Combos Among Developments at AMP 2019

Molecular vendors met in Baltimore at the Association for Molecular Pathology meeting in Baltimore Wednesday for pre-convention corporate workshops and presentations. Not surprisingly, some news was made. Several vendors presented new solutions to chip away at result times. Thermo Fisher Scientific launched its Ion Torrent Genexus System, an integrated next-generation sequencing (NGS) platform featuring an […]

READ MORE..


Major Molecular Diagnostic Vendors Announce Workshops for AMP

As molecular pathologists, pharmaceutical companies and in vitro diagnostic vendors gather in Baltimore MD for the upcoming Association for Molecular Pathology (AMP) in Baltimore, MD. corporate workshops have been announced.  The workshops indicate the direction the industry is going, with new molecular technologies such as mass spec and NGS replacing traditional ones in some cases.   Roche, Abbott […]

READ MORE..